Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
Canada
Health Canada · 8 médicaments
- Act-Hib10 MCG / 0.5 ML + 30 MCG / 0.5 ML · Kit, Powder For Solution · Sanofi Vaccines Canada LTD.
- Infanrix Hexa25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML · Suspension · Glaxosmithkline INC
- Pentacel15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML · Suspension · Sanofi Vaccines Canada LTD.
- Liquid Pedvaxhib7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML · Suspension · Merck Canada INC
Tous les médicaments contenant Haemophilus influenzae type b-prp
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
10 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Infanrix HexaAssociation | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Commercialisé | Glaxosmithkline INC |
| Act-HibAssociation | Canada | 10 MCG / 0.5 ML + 30 MCG / 0.5 ML | Kit, Powder For Solution | Commercialisé | Sanofi Vaccines Canada LTD. |
| PentacelAssociation | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Commercialisé | Sanofi Vaccines Canada LTD. |
| Prohibit Inj VaccineAssociation | Canada | 23 MCG / 0.5 ML + 25 MCG / 0.5 ML | Liquid | Annulé | Aventis Pasteur Limited |
| Pedvaxhib Inj PWSAssociation | Canada | 15 MCG / VIAL + 250 MCG / VIAL | Powder For Solution | Annulé | Merck Manufacturing Division, Division of Merck & Co., INC. |
| PediacelAssociation | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Annulé | Sanofi Vaccines Canada LTD. |
| PentacelAssociation | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Liquid, Powder For Solution | Annulé | Sanofi Vaccines Canada LTD. |
| Liquid PedvaxhibAssociation | Canada | 7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML | Suspension | Annulé | Merck Canada INC |
| Infanrix-Ipv/HibAssociation | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Commercialisé | Glaxosmithkline INC |
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Annulé | Glaxosmithkline INC |
En bref
- Registres
- 1
- Médicaments
- 8
- Laboratoires
- 5